Rethinking Trial Access in Lower-Income Regions
Expanding breast cancer research leadership beyond high-income countries is crucial for building more inclusive global trial networks.
Gen Li, PhD, MBA, president of Phesi, highlights the geographic concentration of breast cancer trial leaders in the US and China, with a positive outlook on global diversity.
Operational Barriers and Opportunities
Traditional business models are a significant barrier to conducting trials in lower-income countries. However, leveraging artificial intelligence (AI) and machine learning can help implement a more patient-centric approach.
- Identifying local leaders to address the lack of local KOLs in underserved areas
- Redistributing trial workloads and improving recruitment using AI to identify and activate new sites
Author's summary: AI-driven models can help expand breast cancer research.
More News
- Elaine Hendrix on Vegan Living, ‘Dancing With the Stars’, and Life After ‘The Parent Trap’
- We cannot sit back to AI
- How to Keep Your Tech Running Offline When the Cloud Fails - Make Tech Easier
- Vampire Survivors Gets Free Balatro Ante Chamber DLC
- Building a stable ‘abode of thought’: Kant’s rules for virtuous thinking
- Why China’s “Taiwan Reunification” Shibboleth Is a Hoax